1. martona55
2. Healydiz
3. robflutie
1.Healydiz 07/09/2018
Assembly Biosciences Initiates Two Phase 2a Trials of ABI-H0731 for the Treatment of Hepatitis B Virus Infection
2.robflutie 03/30/2018
Assembly Biosciences Announces ABI-H0731 Phase 1b Interim Data Accepted as a Late-Breaker Poster at The International Liver Congress™ (EASL)
3.Healydiz 10/07/2017
Up over 100% this year
4.Healydiz 06/08/2018
I love fridays! up 12.4%
5.Healydiz 04/12/2018
Assembly Biosciences Presents Positive Interim Data from Phase 1a and 1b Studies of ABI-H0731 in HBV Patients in a Late-Breaker Session at the EASL Conference
6.robflutie 10/07/2017
Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)INDIANAPOLIS, Oct. 05, 2017-- Assembly Biosciences, Inc., a clinical-stage biotechnology company advancing a new clas
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW